Nature of Operations and Summary of Significant Accounting and Reporting Policies (Details Narrative) |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Jun. 24, 2019
$ / shares
shares
|
Jun. 30, 2019
USD ($)
Integer
$ / shares
shares
|
Jun. 30, 2018
USD ($)
Integer
$ / shares
shares
|
Sep. 21, 2018
shares
|
Sep. 20, 2018
shares
|
Jan. 23, 2018
shares
|
Jan. 22, 2018
shares
|
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Common stock, shares authorized | shares | 100,000,000 | 100,000,000 | 100,000,000 | 4,000,000,000 | 400,000,000 | 400,000,000 | 100,000,000 |
Reverse stock | one-for-five hundred (1:500) | ||||||
Common stock, par value | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | ||||
Cash equivalents | $ | |||||||
Value added tax receivable | $ | $ 5,439 | 6,257 | |||||
Income tax percentage description | On December 22, 2017, the passage of legislation commonly referred to as the Tax Cuts and Jobs Act ("TCJA") was enacted and significantly revised the U.S. income tax law. The TCJA includes changes, which reduce the corporate income tax rate from 34% to 21% for fiscal years beginning after December 31, 2017. | ||||||
Income tax percentage | 21.00% | ||||||
Research and development costs | $ | $ 260,335 | 1,825,728 | |||||
Tax credits | $ | $ 115,437 | $ 179,306 | |||||
Debt conversion percentage | 4.99% | ||||||
Debt conversion percentage, description | Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation, (subject to certain noteholders' ability to increase such limitation to 9.99% upon 60 days' notice to the Company) | ||||||
Stock Options [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | shares | 59,644 | 1,144 | |||||
Convertible Notes Payable [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Number of convertible notes payable converted common shares | Integer | 10 | 20 | |||||
Warrants [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | shares | 59 | 291 | |||||
Common Stock [Member] | |||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||
Antidilutive securities excluded from computation of earnings per share, amount | shares | 1,810,347 | 207,397 |